With significant achievements across various therapeutic areas. The company’s progress included robust cli...
From January to June 2024, Moderna solidified its position as a leader in biotechnology, making substantial progress acr...
From January to June 2024, Illumina demonstrated a dynamic and transformative approach to its business, marking a period...
Between January and June 2024, Gilead Sciences made substantial progress across multiple therapeutic areas, reinforcing ...
Between January and June 2024, Genentech, a leading biotechnology company, made significant ...
From January to June 2024, CSL Limited reinforced its position as a global leader in biopharmaceuticals, making signific...
Between January and June 2024, CRISPR Therapeutics solidified its position as a pioneer in gene-editing technology with ...
BioNTech SE (Nasdaq: BNTX), a global leader in immunotherapy and innovative vaccine development, has reported significan...
Biogen's activities from January to June 2024 reflect a period of strategic initiatives, clinical advancements, and or...
From January to June 2024, Amgen demonstrated significant progress across various therapeutic areas, product lau...
